Prospective Evaluation of Pathways for Preterm Birth
Recruiting
Observational Study
Preterm Birth
Cervix; Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 45
- Sex
- Female
- Study type
- Observational
- Participants needed
- 240 (estimated)
- Sponsor
- John O'Brien, MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single center, prospective cohort study of pregnant patients at high risk for spontaneous preterm birth: patient's with history of spontaneous preterm birth, patient's with a short cervix and patient's symptomatic for preterm birth will be included. A control cohort of nulliparous patients without a short cervix will be recruited to provide baseline data. Plan to enroll 240 patients iden…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Maternal age from 18 to 45 years of age.
* Singleton gestation.
Exclusion Criteria:
* Treatment with vaginal progesterone or intramuscular progestogen within the previous 4 weeks.
* History of congestive heart failure, chronic renal failure, or uncontrolled diabetes mellitus…
Contacts